The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease ; volume:12 ; number:1 ; day:13 ; month:6 ; year:2020 ; pages:1-16 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (13.6.2020), 1-16, 12.2020

Creator: Hadjichrysanthou, Christoforos
Evans, Stephanie
Bajaj, Sumali
Siakallis, Loizos C.
McRae-McKee, Kevin
Wolf, Frank de
Anderson, Roy M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-020-00636-z

URN: urn:nbn:de:101:1-2020081121350498549274

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:50 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hadjichrysanthou, Christoforos
Evans, Stephanie
Bajaj, Sumali
Siakallis, Loizos C.
McRae-McKee, Kevin
Wolf, Frank de
Anderson, Roy M.
SpringerLink (Online service)

Other Objects (12)

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

The dynamics of plasma biomarkers across the Alzheimer’s continuum

Attitudes toward clinical trials across the Alzheimer’s disease spectrum

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum

Biomarkers in Alzheimer’s disease

Estimating Progression Rates Across the Spectrum of Alzheimer’s Disease for Amyloid-Positive Individuals Using National Alzheimer’s Coordinating Center Data

Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum

Economic and caregiver impact of Alzheimer’s disease across the disease spectrum: a cohort study

18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum

Brain imaging biomarkers for the Alzheimer’s Prevention Initiative

Blood biomarkers for Alzheimer’s disease

Neuroimaging Biomarkers for Alzheimer’s Disease

Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

Related objects

Reset password